Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novo Nordisk: FDA diabetes-drug comment deferred
Novo Nordisk: FDA diabetes-drug comment deferred
Novo Nordisk: FDA diabetes-drug comment deferred
Submitted by
admin
on September 23, 2009 - 8:40am
Source:
Marketwatch
News Tags:
Novo Nordisk
FDA
diabetes
liraglutide
Headline:
Novo Nordisk: FDA diabetes-drug comment deferred
Do Not Allow Advertisers to Use My Personal information
